← Evidence map

ArticleCPT: pharmacometrics & systems pharmacology2025

Comprehensive Safety Exposure-Response Analysis to Support Ritlecitinib Dose Selection.

Yeamin Huh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40353635